Form D · Other Health Care

NovoSource, Inc.

Dayton, OH · CIK 0001553409

Offering snapshot reported Jul 25, 2013 · SEC filing

Reported sold: $1.84M
Investors reported: 33
Minimum accepted: $3K
First sale: Jun 1, 2013

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$718,060 → $1,840,750
Reported investors10 → 33

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Jul 25, 2013	Amendment	$1,840,750	$1,122,690vs Jun 21, 2013	33	SEC filing
Jun 21, 2013	Initial	$718,060	No comparison	10	SEC filing
Nov 21, 2012	Amendment	$842,500	$105,000vs Nov 7, 2012	21	SEC filing
Nov 7, 2012	Initial	$737,500	No comparison	16	SEC filing

Offering details

Securities: Equity, Debt
Exemptions: 06
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-198378

Company may elect to close offering prior to the sale of all stock and notes.

No Sales Commission or Finders' Fee Expenses.

Source: Form D, filed Jul 25, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Andrew D. Cothrel	Executive
Thomas Bradley Harris	Director
Douglas Hawkins	Director
Harold Linville	Director, Executive, Promoter
Jonathan J. May	Director, Executive, Promoter

Issuer details

Industry: Other Health Care (See others in industry)

Address:

714 E. Monument Avenue Suite 220
Dayton, OH, 45402